Liava Christina, Starlinger Patrick, Kamath Patrick S, Hilscher Moira B
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Hepatobiliary and Pancreas Surgeon Department, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Gastro Hep Adv. 2025 Mar 15;4(6):100655. doi: 10.1016/j.gastha.2025.100655. eCollection 2025.
Gallbladder cancer (GBC) is a rare type of cancer with a high rate of cancer-related mortality because it is usually diagnosed at an advanced stage; however, it may also be incidentally detected postcholecystectomy for cholelithiasis. We aimed to identify risk factors for GBC incidentally found during cholecystectomy for cholelithiasis.
We performed a case-control study including patients with histologically confirmed GBC incidentally found during cholecystectomy for cholelithiasis and controls who underwent cholecystectomy for cholelithiasis. Patient and control data were collected retrospectively using the electronic patient database. Risk factors were identified using logistic regression analysis.
In total, 76 GBC patients and 1065 controls were included in the study. Among GBC patients, 65.8% presented acutely, 30.3% had chronic biliary symptoms, 0.3% were asymptomatic, and 43.4% had known cholelithiasis before symptoms. On multivariate analysis, when compared with controls, GBC was significantly associated with female gender (80.3% vs 56.7% controls, < .001), age ≥ 68 years (86.8% vs 48.4%, < .001), gallstone size ≥1.70 cm (73.2% vs 28.2% controls, < .001), ascending cholangitis (12.5% vs 4.1%, < .001), anemia prior to cholecystectomy (33.3% vs 13.9%, < .001), and duration of cholelithiasis ≥5 years (31.6% vs 10.2%, = .011). These factors were included in a predictive model that was validated in internal and independent datasets with a sensitivity of 87%, specificity of 59%, and accuracy of 73%.
In this case-control study, 5 independent risk factors were identified for early detection of asymptomatic individuals with cholelithiasis at high risk of harboring GBC that might benefit from cholecystectomy. High clinical suspicion for GBC improves the management of patients with cholelithiasis through advanced imaging work-up and appropriate surgical approach, avoiding reoperations.
胆囊癌(GBC)是一种罕见的癌症,因其通常在晚期才被诊断出来,所以癌症相关死亡率很高;然而,它也可能在因胆结石行胆囊切除术后被偶然发现。我们旨在确定在因胆结石行胆囊切除术时偶然发现的胆囊癌的危险因素。
我们进行了一项病例对照研究,纳入因胆结石行胆囊切除术时偶然发现经组织学确诊为胆囊癌的患者以及因胆结石行胆囊切除术的对照者。使用电子患者数据库回顾性收集患者和对照者的数据。通过逻辑回归分析确定危险因素。
该研究共纳入76例胆囊癌患者和1065例对照者。在胆囊癌患者中,65.8%为急性发病,30.3%有慢性胆道症状,0.3%无症状,43.4%在出现症状前已知患有胆结石。多因素分析显示,与对照者相比,胆囊癌与女性性别(80.3%对56.7%,P<0.001)、年龄≥68岁(86.8%对48.4%,P<0.001)、胆结石大小≥1.70 cm(73.2%对28.2%,P<0.001)、化脓性胆管炎(12.5%对4.1%,P<0.001)、胆囊切除术前贫血(33.3%对13.9%,P<0.001)以及胆结石病程≥5年(31.6%对10.2%,P=0.011)显著相关。这些因素被纳入一个预测模型,该模型在内部和独立数据集中得到验证,敏感性为87%,特异性为59%,准确性为73%。
在这项病例对照研究中,确定了5个独立的危险因素,用于早期发现有患胆囊癌高风险的无症状胆结石患者,这些患者可能从胆囊切除术中获益。对胆囊癌的高度临床怀疑通过先进的影像学检查和适当的手术方法改善了胆结石患者的管理,避免了再次手术。